CVS Health Org Chart: Corporate Structure, Board of Directors and Executive Leadership (2026)

As of September 30, 2026, CVS Health is led by David Joyner, Chairman and CEO, with Brian Newman as Executive Vice President and Chief Financial Officer and Michael F. Mahoney as Lead Independent Director. CVS Health Corporation reports four segments: Health Care Benefits (Aetna), Health Services (CVS Caremark and the health care delivery businesses), Pharmacy & Consumer Wellness (CVS Pharmacy) and Corporate/Other. This page draws on the Form 10-K for fiscal 2025, the Form 10-Q for the quarter ended June 30, 2026, the 2026 proxy statement, the August 5, 2026 earnings call and CVS Health's own leadership and board pages.

CVS Health key facts

Legal name	CVS Health Corporation (Form 10-K, fiscal year ended Dec. 31, 2025, cover page)
State of incorporation	Delaware (Form 10-K FY2025, cover page)
Headquarters	One CVS Drive, Woonsocket, Rhode Island 02895 (Form 10-K FY2025, cover page)
Ticker and exchange	CVS, New York Stock Exchange (Form 10-K FY2025, Item 5)
Fiscal 2025 total revenues	$402.1 billion, up 7.8% from 2024 (Form 10-K FY2025, Item 7)
Q2 2026 total revenues	$106.1 billion for the quarter ended June 30, 2026 (Form 10-Q, Q2 2026)
Employees	Over 300,000 colleagues as of Dec. 31, 2025, about 73% full-time (Form 10-K FY2025, Item 1, Human Capital)
Locations	8,979 stores at year-end 2025 (including pharmacies inside Target and other retail chains), more than 800 MinuteClinic locations and 246 leased primary care centers in 27 states (Form 10-K FY2025, Items 1, 2 and 7)
Medical membership	26.0 million as of June 30, 2026 (Form 10-Q, Q2 2026)
Reportable segments	Health Care Benefits; Health Services; Pharmacy & Consumer Wellness; Corporate/Other (Form 10-Q, Q2 2026, segment note)

What CVS Health's filings tell a seller

Strategic priorities

On the August 5, 2026 earnings call, Joyner framed the goal as becoming America's most trusted health care company and named the work behind it: Aetna margin recovery, becoming the provider partner of choice, the Caremark move to net cost pricing models, and a direct-to-consumer GLP-1 offering that covers every FDA-approved GLP-1. A pitch tied to one of those named programs lands with a sponsor who already owns a target for it.

The full Databahn report ties each priority to the executive accountable for it and the budget line that funds it.

What CVS Health's executives are paid to deliver

The 2025 annual bonus plan weighted adjusted operating income at 60%, the adjusted SG&A ratio at 20% and Net Promoter Score at 20%, and funded at 142.3%. The 2025 to 2027 performance shares weight three-year cumulative adjusted EPS at 70%, with the remaining 30% split evenly across debt paydown, the share of Medicare members in 4+ Star plans, and the share of customers using two or more CVS Health offerings. Sellers who can show movement on cost ratios, Stars or cross-enterprise customer counts are speaking to numbers that set executive pay.

The full Databahn report maps each metric to the leader who carries it and the conversation that opens it.

Spending and capital plans

Gross capital expenditures were about $2.8 billion in 2025, and roughly 77% went to technology, digital and other strategic initiatives. CVS Health spent $1.54 billion on property and equipment in the first half of 2026, and management repeated a commitment made in 2025 to invest more than $20 billion in technology over the next decade. The 2026 outlook assumes no share repurchases, which leaves cash flow pointed at debt reduction and operating investment.

The full Databahn report shows where the technology dollars are concentrated and which teams control them.

Acquisitions and integrations

In May 2025 CVS Health agreed to buy the prescription files of certain Rite Aid pharmacies and to acquire and operate certain Rite Aid stores in Idaho, Oregon and Washington for $465 million, with closings completed in the third quarter of 2025. The same year it divested its Medicare Shared Savings Program operations to Wellvana Health (March), deconsolidated Omnicare (September), and recorded a $5.7 billion goodwill impairment on the Health Care Delivery unit built from the 2023 Oak Street Health and Signify Health deals. Integration costs for Oak Street Health and Signify Health still appear in the 2026 results.

The full Databahn report covers who runs each integration and where the open work sits.

Technology and AI initiatives

CVS Health began a targeted launch of its Health 100 platform and HIO, an AI-powered consumer assistant, in July 2026. Aetna's AI-enabled Claims Assist Manager is expected to cut claims processing time by more than 20%, and 83% of Aetna prior authorizations are approved in real time. In retail pharmacy, conversational AI has absorbed hundreds of millions of calls and freed about 1 million pharmacist hours, according to the call. Management describes the company as moving toward a consumer health care technology business.

The full Databahn report names the technology owners behind each program and the gaps they have described.

Risk factors and pressure points

The 10-K leads its risk list with the difficulty of forecasting health care and benefit costs, and it flags state laws that could bar pharmacy licenses for pharmacies affiliated with a PBM. On the August call, management said it is challenging laws in Arkansas and Tennessee, expects 340B program pressure to be a 2027 headwind, and expects Caremark membership to decline in 2027. Vendors that help with cost forecasting, regulatory change or client retention are working on problems the company has put in writing.

The full Databahn report ranks these pressures by business unit and links each to its owner.

How vendors get approved

CVS Health says it assesses the cybersecurity risk profiles of key third parties, and its own systems are assessed against HIPAA, NIST 800-53, SOC 1, SOC 2 Type 2, HITRUST, PCI DSS and National Association of Insurance Commissioners standards. A vendor holding SOC 2 Type 2 and HITRUST evidence before procurement asks for it shortens the review.

The full Databahn report outlines the review path and the people who sign off at each step.

Who owns security and data decisions

The Chief Information Security Officer reports to the Chief Experience and Technology Officer (Tilak Mandadi), who reports to the CEO. The board's Audit Committee, chaired by Fernando Aguirre, oversees cybersecurity, privacy and information governance and gets CISO and CETO briefings at least bi-quarterly. The Health Services and Technology Committee, chaired by Jeffrey R. Balser, reviews the technology and digital portfolio and how those assets are procured or developed.

The full Databahn report names the security, privacy and data leaders below the CETO.

Leadership changes

Brian Newman became CFO on May 12, 2025, replacing Thomas F. Cowhey. Joyner added the board chair role on January 1, 2026, Roger N. Farah retired from the board at the May 14, 2026 annual meeting, and John E. Gallina joined the board in March 2026. Larry M. Robbins left the board on August 13, 2026, and Teresa A. Heitsenrether joins on November 18, 2026. Siddharth Tenneti currently leads Pharmacy and Consumer Wellness on an interim basis. New leaders reset vendor lists, so the next few quarters are an open window.

The full Databahn report tracks each change and what the new leader has said about priorities.

Systems and business transformations

The Q2 2026 10-Q reports no material change in internal control over financial reporting. The operating changes are in pricing models: CVS Pharmacy completed its move to cost-based reimbursement (CVS CostVantage) across several businesses in 2025, and Caremark is moving clients to net cost pricing. On the call, Joyner said infrastructure changes are under way in care delivery to speed data sharing with providers and payers.

The full Databahn report details the systems behind each transition and who sponsors them.

Shareholder pressure

The 2026 proxy carried a stockholder proposal to let holders of 10% of shares request a record date for action by written consent, down from the current 25%. The board recommended against it, noting stockholders rejected substantially identical proposals in 2021 and 2025. Management also reached out to holders of about 60% of outstanding stock in late 2025 and early 2026, partly to discuss the prior say-on-pay vote.

The full Databahn report explains how investor pressure shows up in this year's operating decisions.

Locations by territory

At the end of 2025 CVS Health ran 8,979 stores, including about 1,870 pharmacies inside other retail chains, plus more than 800 MinuteClinic locations and 246 leased primary care centers across 27 states. The headquarters complex in Woonsocket, Rhode Island covers about one million square feet, and Aetna's owned complex in Hartford, Connecticut covers about 1.7 million. The filings don't break store counts out by state.

The full Databahn report maps regional leadership to these footprints.

What management told analysts

On August 5, 2026, CVS Health raised 2026 adjusted EPS guidance by $0.60 to $7.90 to $8.10, set total revenues at a minimum of $414 billion and cash flow from operations at a minimum of $11.5 billion, and called a 2027 adjusted EPS floor of $8.44. Management reaffirmed a mid-teens adjusted EPS compound annual growth rate from 2025 through 2028. Those are public commitments, so proposals that protect or add to them get attention.

The full Databahn report tracks each commitment by segment and the executive answering for it.

CVS Health org chart FAQ

Who is the CEO of CVS Health?

David Joyner is Chairman and CEO of CVS Health. He became CEO in October 2024 and added the board chair role on January 1, 2026.

Who is the CFO of CVS Health?

Brian Newman is Executive Vice President and Chief Financial Officer, effective May 12, 2025. He was previously CFO of United Parcel Service.

Who is on CVS Health's board of directors?

The board includes J. David Joyner (Chairman), Michael F. Mahoney (Lead Independent Director), Fernando Aguirre, Jeffrey R. Balser, C. David Brown II, Alecia A. DeCoudreaux, Anne M. Finucane, John E. Gallina, J. Scott Kirby, Leslie V. Norwalk, Guy P. Sansone and Douglas H. Shulman. Teresa A. Heitsenrether joins on November 18, 2026.

How is CVS Health organized?

CVS Health reports four segments: Health Care Benefits (Aetna), Health Services (CVS Caremark and health care delivery, including Oak Street Health, Signify Health and MinuteClinic), Pharmacy & Consumer Wellness (CVS Pharmacy) and Corporate/Other.

What companies does CVS Health own?

CVS Health owns Aetna, CVS Caremark, CVS Pharmacy, Oak Street Health, Signify Health, MinuteClinic and Cordavis, its biosimilar subsidiary. It added certain Rite Aid prescription files and stores in Idaho, Oregon and Washington in 2025.

Who oversees cybersecurity at CVS Health?

The Chief Information Security Officer leads cybersecurity and reports to Tilak Mandadi, Chief Experience and Technology Officer, who reports to the CEO. The board's Audit Committee, chaired by Fernando Aguirre, oversees cybersecurity risk.

Who runs Aetna?

Steve Nelson is Executive Vice President and President, Aetna. Katerina Guerraz is Chief Operating Officer of Aetna and President of Medicaid.

What's in the full Databahn report

• How to position against the incumbent vendor in your category
• Who to call, in what order, with verified contact details
• The questions to ask each executive
• The questions CVS Health is likely to ask you back

Request a custom sales intelligence report

Walk into your first CVS Health meeting knowing who decides, what they're measured on and what to say.